These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 21809678

  • 21. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

  • 22. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.
    Monga DK, O'Connell MJ.
    Ann Surg Oncol; 2006 Aug; 13(8):1021-34. PubMed ID: 16897272
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer.
    Recchia F, Candeloro G, Necozione S, Bratta M, Bisegna R, Rea S.
    Am J Clin Oncol; 2008 Aug; 31(4):323-8. PubMed ID: 18845989
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [Abstract] [Full Text] [Related]

  • 28. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.
    Des Guetz G, Lecaille C, Mariani P, Bennamoun M, Uzzan B, Nicolas P, Boisseau A, Sastre X, Cucherousset J, Lagorce C, Schischmanoff PO, Morere JF.
    Anticancer Res; 2010 Oct; 30(10):4297-301. PubMed ID: 21036755
    [Abstract] [Full Text] [Related]

  • 31. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA.
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract] [Full Text] [Related]

  • 32. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M, Yasuda H, Koda K, Yamazaki M, Tezuka T, Takenoue T, Kosugi C, Higuchi R, Yamamoto S, Watayo Y, Yagawa Y, Suzuki M.
    Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
    [Abstract] [Full Text] [Related]

  • 33. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B, Van Nieuwenhove Y, Aerts M, Fontaine C, Vermeij J, Schallier D, Decoster L, De Mey J, Vandenbroucke F, Hoorens A, Delvaux G, De Gréve J.
    Anticancer Res; 2006 Sep; 26(1B):611-9. PubMed ID: 16739329
    [Abstract] [Full Text] [Related]

  • 34. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

  • 35. Unresectable liver metastases in colorectal cancer: review of current strategies.
    Sueur B, Pellerin O, Voron T, Pointet AL, Taieb J, Pernot S.
    Minerva Chir; 2016 Dec; 71(6):382-397. PubMed ID: 27733753
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response.
    Kern W, Beckert B, Lang N, Waggershauser T, Braess J, Schalhorn A, Hiddemann W.
    Anticancer Res; 2000 Dec; 20(6D):4973-5. PubMed ID: 11326650
    [Abstract] [Full Text] [Related]

  • 38. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [Abstract] [Full Text] [Related]

  • 39. Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.
    Kosmider S, Tan TH, Yip D, Dowling R, Lichtenstein M, Gibbs P.
    J Vasc Interv Radiol; 2011 Jun; 22(6):780-6. PubMed ID: 21515072
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.
    Agarwal A, Daly KP, Butler-Bowen H, Saif MW.
    Anticancer Res; 2014 Nov; 34(11):6775-8. PubMed ID: 25368290
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.